Brief: Standard Biotools Proteomics Profiling Reveals Unique Biomarkers And Insights Into Nonalcoholic Steatohepatitis
18/09/2024 13:56
Sept 18 (Reuters) - Standard BioTools Inc LAB.O :
* STANDARD BIOTOOLS PROTEOMICS PROFILING REVEALS UNIQUE
BIOMARKERS
AND INSIGHTS INTO NONALCOHOLIC STEATOHEPATITIS (NASH)
Source text for Eikon: ID:nGNXbdfLyL
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07